810 related articles for article (PubMed ID: 26976569)
1. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.
Ren Q; Ma M; Ishima T; Morisseau C; Yang J; Wagner KM; Zhang JC; Yang C; Yao W; Dong C; Han M; Hammock BD; Hashimoto K
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1944-52. PubMed ID: 26976569
[TBL] [Abstract][Full Text] [Related]
2. The effects of sEH inhibitor on depression-like behavior and neurogenesis in male mice.
Wu Q; Cai H; Song J; Chang Q
J Neurosci Res; 2017 Dec; 95(12):2483-2492. PubMed ID: 28699310
[TBL] [Abstract][Full Text] [Related]
3. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
[TBL] [Abstract][Full Text] [Related]
4. TPPU, a sEH Inhibitor, Attenuates Corticosterone-Induced PC12 Cell Injury by Modulation of BDNF-TrkB Pathway.
Wu Q; Song J; Meng D; Chang Q
J Mol Neurosci; 2019 Mar; 67(3):364-372. PubMed ID: 30644034
[TBL] [Abstract][Full Text] [Related]
5. Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern.
Ostermann AI; Herbers J; Willenberg I; Chen R; Hwang SH; Greite R; Morisseau C; Gueler F; Hammock BD; Schebb NH
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):131-7. PubMed ID: 26117215
[TBL] [Abstract][Full Text] [Related]
6. SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway.
Jiang B; Wang F; Yang S; Fang P; Deng ZF; Xiao JL; Hu ZL; Chen JG
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522427
[TBL] [Abstract][Full Text] [Related]
7. Astrocytic Epoxyeicosatrienoic Acid Signaling in the Medial Prefrontal Cortex Modulates Depressive-like Behaviors.
Xiong W; Cao X; Zeng Y; Qin X; Zhu M; Ren J; Wu Z; Huang Q; Zhang Y; Wang M; Chen L; Turecki G; Mechawar N; Chen W; Yi G; Zhu X
J Neurosci; 2019 Jun; 39(23):4606-4623. PubMed ID: 30902874
[TBL] [Abstract][Full Text] [Related]
8. The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling.
Luo A; Wu Z; Li S; McReynolds CB; Wang D; Liu H; Huang C; He T; Zhang X; Wang Y; Liu C; Hammock BD; Hashimoto K; Yang C
J Transl Med; 2023 Feb; 21(1):71. PubMed ID: 36732752
[TBL] [Abstract][Full Text] [Related]
9. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
[TBL] [Abstract][Full Text] [Related]
10. Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation.
Ma M; Ren Q; Yang J; Zhang K; Xiong Z; Ishima T; Pu Y; Hwang SH; Toyoshima M; Iwayama Y; Hisano Y; Yoshikawa T; Hammock BD; Hashimoto K
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7083-7088. PubMed ID: 30890645
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
[TBL] [Abstract][Full Text] [Related]
13. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
[TBL] [Abstract][Full Text] [Related]
14. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
[TBL] [Abstract][Full Text] [Related]
15. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.
Jonnalagadda D; Wan D; Chun J; Hammock BD; Kihara Y
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925035
[TBL] [Abstract][Full Text] [Related]
16. Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine.
Wan X; Fujita Y; Chang L; Wei Y; Ma L; Wuyun G; Pu Y; Hammock BD; Hashimoto K
Neuropsychopharmacol Rep; 2020 Dec; 40(4):412-416. PubMed ID: 32896112
[TBL] [Abstract][Full Text] [Related]
17. Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders.
Hashimoto K
Front Pharmacol; 2019; 10():36. PubMed ID: 30761004
[TBL] [Abstract][Full Text] [Related]
18. Soluble Epoxide Hydrolase Pharmacological Inhibition Ameliorates Experimental Acute Pancreatitis in Mice.
Bettaieb A; Chahed S; Bachaalany S; Griffey S; Hammock BD; Haj FG
Mol Pharmacol; 2015 Aug; 88(2):281-90. PubMed ID: 25993999
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous Target-Mediated Drug Disposition Model for Two Small-Molecule Compounds Competing for Their Pharmacological Target: Soluble Epoxide Hydrolase.
Wu N; Hammock BD; Lee KSS; An G
J Pharmacol Exp Ther; 2020 Jul; 374(1):223-232. PubMed ID: 32238455
[TBL] [Abstract][Full Text] [Related]
20. Deletion of serine racemase confers D-serine -dependent resilience to chronic social defeat stress.
Dong C; Zhang JC; Ren Q; Ma M; Qu Y; Zhang K; Yao W; Ishima T; Mori H; Hashimoto K
Neurochem Int; 2018 Jun; 116():43-51. PubMed ID: 29550603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
